Posts

Last Month in Oncology: FDA Cancer News Roundup

The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened last month. Medscape Medical News source https://www.medscape.com/viewarticle/last-month-oncology-fda-cancer-news-roundup-2024a1000k5n?src=rss

Myasthenia Gravis: Where Does Traditional Therapy Fit in?

Neurologists debate the data on familiar immunosuppressive agents. Medscape Medical News source https://www.medscape.com/viewarticle/myasthenia-gravis-where-does-traditional-therapy-fit-2024a1000k2g?src=rss

HS Linked to Increased Risk for Eating Disorders

According to the study’s lead author, the topic has not been explored previously. Medscape Medical News source https://www.medscape.com/viewarticle/hs-linked-increased-risk-eating-disorders-2024a1000k2b?src=rss

FDA Advisers Vote Against Lexicon Pharma's Add-on Drug for Type 1 Diabetes

Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' add-on treatment to insulin therapy for... Reuters Health Information source https://www.medscape.com/s/viewarticle/fda-advisers-vote-against-lexicon-pharmas-add-drug-type-1-2024a1000k00?src=rss

Semiannual Time Changes Linked to Accidents, Heart Attacks

Adopting year-round standard time could help people maintain healthier sleep-wake rhythms, says a University of Calgary professor. Medscape Medical News source https://www.medscape.com/viewarticle/semiannual-time-changes-linked-accidents-heart-attacks-2024a1000jzk?src=rss

GLP-1 Use Presurgery Safe but No Weight Loss Boost

Use of a GLP-1 RA before bariatric surgery is likely safe, but unlikely to boost weight loss. Medscape Medical News source https://www.medscape.com/viewarticle/glp-1-use-presurgery-safe-no-weight-loss-boost-2024a1000jxq?src=rss